膝关节肿胀治疗市场规模、份额、成长分析（按类型、按药物疗法、按手术、按最终用户、按地区）- 行业预测 2025-2032

2023 年膝盖肿胀治疗市场规模价值 20.9 亿美元，预计将从 2024 年的 21.8 亿美元增长到 2032 年的 31.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.5%。

由于非手术医疗保健解决方案的趋势日益突出，膝盖肿胀治疗市场可能面临成长挑战。与传统手术方案相比，患者越来越倾向于治疗和准备治疗，这标誌着微创和非侵入性方法的转变。人们对包括膝关节关节重建在内的外科治疗的潜在副作用和併发症的认识不断提高，这正在推动患者偏好的转变。随着人们对手术风险的了解越来越多，他们积极寻找侵入性较小、恢復时间更快且仍能提供类似效果的替代方法。这种不断变化的情况要求重新评估行销策略，以符合患者对更安全、更保守的治疗方法的偏好。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

膝关节肿胀治疗市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 製药
• 病人自控镇痛泵
• 神经阻断
• 脂质体Bupivacaine
• 外科手术

膝盖肿胀治疗市场规模（按药物疗法和复合年增长率） (2025-2032)

• 市场概览
• 阿片类药物
• 皮质类固醇
• 其他的

膝关节肿胀治疗市场规模（按手术类型和复合年增长率） (2025-2032)

• 市场概览
• 关节穿刺术
• 关节镜
• 膝关节关节重建
  • 全膝关节关节重建
  • 单髁膝关节关节重建
  • 其他的

膝盖肿胀治疗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 指定诊所
• 门诊手术中心
• 其他的

膝关节肿胀治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Stryker Corporation（USA）
• Ossur（Iceland）
• Smith & Nephew（United Kingdom）
• Zimmer Biomet（USA）
• Arthrex（USA）
• DJO Global（USA）
• Medacta International（Switzerland）
• B. Braun Melsungen（Germany）
• Exactech（USA）
• Wright Medical Group（USA）
• Corin Group（United Kingdom）
• MicroPort Orthopedics（China）
• Aesculap Implant Systems（Germany）
• Tornier NV（Netherlands）
• Bioventus（USA）
• Pfizer（USA）
• Novartis（Switzerland）

结论和建议

Swollen Knee Treatment Market size was valued at USD 2.09 billion in 2023 and is poised to grow from USD 2.18 billion in 2024 to USD 3.11 billion by 2032, growing at a CAGR of 4.5% during the forecast period (2025-2032).

The swollen knee treatment market is likely to encounter growth challenges stemming from a noticeable trend towards non-surgical healthcare solutions. Patients are increasingly favoring therapeutic and preparatory treatments over traditional surgical options, demonstrating a shift towards minimally invasive and non-invasive approaches. Heightened awareness of the potential side effects and complications associated with surgical treatments, including knee arthroplasty, is driving this change in patient preferences. As individuals become more educated about the risks of surgical procedures, they are actively seeking alternative methods that provide similar effectiveness with less invasiveness and quicker recovery times. This evolving landscape necessitates a reevaluation of market strategies to align with the patients' preferences for safer and more conservative treatment options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segments Analysis

Global Swollen Knee Treatment Market is segmented by Type, Medications, Surgery, End User and region. Based on Type, the market is segmented into Medications, Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery. Based on Medications, the market is segmented into Opioids, Corticosteroids and Others. Based on Surgery, the market is segmented into Arthrocentesis, Arthroscopy and Knee Replacement. Based on End User, the market is segmented into Hospitals, Designated Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Swollen Knee Treatment Market

One of the key market drivers for the global swollen knee treatment market is the rising prevalence of knee-related disorders, such as osteoarthritis, rheumatoid arthritis, and sports injuries among the aging population. As the global demographic shifts towards an older population, the incidence of knee problems is increasing, necessitating effective treatment options. Additionally, lifestyle factors such as obesity and increased physical activity contribute to knee joint stress, leading to a higher demand for medical interventions. These factors, combined with advancements in treatment technologies and a growing emphasis on preventive care, are fueling the expansion of the swollen knee treatment market.

Restraints in the Swollen Knee Treatment Market

The Swollen Knee Treatment market faces significant restraints, primarily due to the financial barriers associated with advanced treatment options like knee replacement surgery. The total expenses for such procedures can be substantial, covering pre-operative evaluations, the surgery itself, post-operative care, and rehabilitation costs. These financial burdens can limit access for patients who may already be struggling with economic constraints, making it difficult for them to benefit from vital surgical interventions. Consequently, addressing these financial challenges is crucial to reducing healthcare disparities and ensuring equitable access to essential medical treatments for all individuals, regardless of their financial situation.

Market Trends of the Swollen Knee Treatment Market

The Swollen Knee Treatment market is witnessing a significant upward trend driven by advancements in medical device technology specifically tailored for knee-related solutions. Innovations in knee braces, supports, and orthotic implants are transforming treatment approaches for various orthopedic conditions, resulting in enhanced patient comfort and therapeutic outcomes. These state-of-the-art devices offer targeted support, stability, and optimal alignment, catering to a diverse range of knee issues, from acute injuries to chronic ailments. This continuous evolution not only enriches the treatment landscape but also empowers healthcare professionals to customize interventions, thereby meeting individual patient needs and enhancing the overall quality of care in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Swollen Knee Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Medications
• Patient-controlled Analgesia Pumps
• Nerve Blocks
• Liposomal Bupivacaine
• Surgery

Global Swollen Knee Treatment Market Size by Medications & CAGR (2025-2032)

• Market Overview
• Opioids
• Corticosteroids
• Others

Global Swollen Knee Treatment Market Size by Surgery & CAGR (2025-2032)

• Market Overview
• Arthrocentesis
• Arthroscopy
• Knee Replacement
  • Total Knee Replacement
  • Unicompartmental Knee Replacement
  • Others

Global Swollen Knee Treatment Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Designated Clinics
• Ambulatory Surgical Centers
• Others

Global Swollen Knee Treatment Market Size & CAGR (2025-2032)

• North America (Type, Medications, Surgery, End User)
  • US
  • Canada
• Europe (Type, Medications, Surgery, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Medications, Surgery, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Medications, Surgery, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Medications, Surgery, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ossur (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DJO Global (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medacta International (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exactech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Orthopedics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap Implant Systems (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tornier N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations